Author:
Arslani Ketina,Gualandro Danielle M.,Puelacher Christian,Lurati Buse Giovanna,Lampart Andreas,Bolliger Daniel,Schulthess David,Glarner Noemi,Hidvegi Reka,Kindler Christoph,Blum Steffen,Cardozo Francisco A. M.,Caramelli Bruno,Gürke Lorenz,Wolff Thomas,Mujagic Edin,Schaeren Stefan,Rikli Daniel,Campos Carlos A.,Fahrni Gregor,Kaufmann Beat A.,Haaf Philip,Zellweger Michael J.,Kaiser Christoph,Osswald Stefan,Steiner Luzius A.,Mueller Christian,Gueckel Johanna,Liffert Marcel,Kanhouche Gabriel,Sazgary Lorraine,Yu Pai C.,Prepoudis Alexandra,Shrestha Samyut,Lopez-Ayala Pedro,Freese Michael,Mitrovic Sandra,Rentsch Katharina,Hammerer-Lerchner Angelika,
Abstract
AbstractPatients developing perioperative myocardial infarction/injury (PMI) have a high mortality. PMI work-up and therapy remain poorly defined. This prospective multicenter study included high-risk patients undergoing major non-cardiac surgery within a systematic PMI screening and clinical response program. The frequency of cardiovascular imaging during PMI work-up and its yield for possible type 1 myocardial infarction (T1MI) was assessed. Automated PMI detection triggered evaluation by the treating physician/cardiologist, who determined selection/timing of cardiovascular imaging. T1M1 was considered with the presence of a new wall motion abnormality within 30 days in transthoracic echocardiography (TTE), a new scar or ischemia within 90 days in myocardial perfusion imaging (MPI), and Ambrose-Type II or complex lesions within 7 days of PMI in coronary angiography (CA). In patients with PMI, 21% (268/1269) underwent at least one cardiac imaging modality. TTE was used in 13% (163/1269), MPI in 3% (37/1269), and CA in 5% (68/1269). Cardiology consultation was associated with higher use of cardiovascular imaging (27% versus 13%). Signs indicative of T1MI were found in 8% of TTE, 46% of MPI, and 63% of CA. Most patients with PMI did not undergo any cardiovascular imaging within their PMI work-up. If performed, MPI and CA showed high yield for signs indicative of T1MI.Trial registration:https://clinicaltrials.gov/ct2/show/NCT02573532.
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献